GlassScriptPhysician profile
Isaac H Tawfik
NPI 1073612990
$22,671.68
in general payments reported to CMS, 2019-2025
60 companies · $1,677 in 2025
The $1,677 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $1,026 · 2021: $1,461 · 2022: $2,303 · 2023: $2,820 · 2024: $2,050 · 2025: $1,677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,647 · Travel and Lodging: $636 · Education: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,647.36 |
| Travel and Lodging | $635.83 |
| Education | $264.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $8,778.30 | 2019-2025 | |
| Philips North America LLC | $1,688.73 | 2019-2024 | (5044) Mcot |
| Abbott Laboratories | $1,505.67 | 2019-2024 | Perclose Prostyle, Thoratec Heartmate 3 Lvas Implant Kit, Jeti |
| Irhythm Technologies, INC. | $808.06 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Janssen Pharmaceuticals, INC | $792.54 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $680.59 | 2019-2025 | Farxiga, Lynparza |
| Amgen INC. | $663.41 | 2019-2025 | Repatha, Repatha |
| Actelion Pharmaceuticals US, INC. | $648.06 | 2020-2025 | Uptravi, Opsumit, Opsynvi |
| Boston Scientific Corporation | $579.39 | 2019-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Merck Sharp & Dohme LLC | $571.24 | 2021-2025 | Verquvo, Winrevair, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $531.13 | 2020-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $478.23 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $456.88 | 2019-2025 | Eliquis, Camzyos |
| Bard Peripheral Vascular, INC. | $410.00 | 2019-2024 | Venclose Maven Catheter |
| Medtronic, INC. | $335.63 | 2021-2025 | Abre, Onyx Frontier, Ffrangio |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $327.17 | 2019-2025 | |
| Cardiovascular Systems INC. | $305.34 | 2020-2023 | Diamondback Peripheral |
| Abiomed | $303.30 | 2023-2025 | Impella |
| Cvrx, INC. | $232.01 | 2021-2024 | Barostim Neo System |
| Medtronic Vascular, INC. | $208.73 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $189.99 | 2024-2025 | Amvuttra, Onpattro |
| Bayer Healthcare Pharmaceuticals INC. | $183.97 | 2022-2025 | |
| Acist Medical Systems, INC. | $169.57 | 2023-2024 | |
| Novo Nordisk INC | $159.52 | 2022-2025 | Wegovy, Ozempic |
| Amarin Pharma, INC. | $136.29 | 2019-2023 | |
| Penumbra, INC. | $110.15 | 2024 | Indigo System |
| Esperion Therapeutics, INC. | $103.44 | 2021-2025 | Nexletol |
| Arbor Pharmaceuticals, INC. | $95.99 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $91.40 | 2019-2025 | Evkeeza |
| Silk Road Medical, INC. | $78.40 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Heartflow, INC. | $74.55 | 2025 | |
| Kestra Medical Technology Services, INC. | $73.21 | 2024 | Assure Wcd |
| United Therapeutics Corporation | $71.73 | 2024-2025 | Tyvaso, Tyvaso |
| Kiniksa Pharmaceuticals, LTD. | $71.46 | 2022-2023 | Arcalyst |
| Imperative Care, INC | $69.54 | 2025 | Prodigy Catheter, Symphony Catheter, Prodigy Twist |
| W. L. Gore & Associates, INC. | $66.07 | 2020-2022 | |
| Scpharmaceuticals INC. | $50.99 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $41.68 | 2019-2022 | |
| Stryker Corporation | $40.41 | 2025 | Artix Mt |
| Angiodynamics, INC. | $39.02 | 2019-2023 | Auryon Laser System 100-120 Vac |
| Akcea Therapeutics, INC. | $36.67 | 2020-2021 | |
| Misonix INC | $33.85 | 2019 | |
| Daiichi Sankyo INC. | $31.93 | 2022-2023 | Injectafer |
| Bardy Diagnostics, INC. | $30.00 | 2021 | |
| Lundbeck LLC | $27.09 | 2020 | |
| Genzyme Corporation | $26.81 | 2021-2022 | |
| Cashflow Solutions, LLC | $26.42 | 2023 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Kowa Pharmaceuticals America, INC. | $26.32 | 2019-2022 | |
| Chiesi USA, INC. | $24.74 | 2025 | Juxtapid |
| Sensible Medical Innovations INC | $22.96 | 2019 | |
| Agepha Pharma Fz LLC | $19.71 | 2024 | Lodoco |
| Baxter Healthcare | $17.65 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Biogen, INC. | $17.08 | 2024 | Skyclarys |
| Kiniksa Pharmaceuticals International, Plc | $17.00 | 2024 | Arcalyst |
| Shockwave Medical, INC | $16.99 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Tactile Systems Technology INC | $16.20 | 2019 | |
| Impulse Dynamics (USA) INC. | $15.20 | 2023 | Optimizer |
| Cardinal Health 200 LLC | $15.02 | 2019 | |
| Gilead Sciences, INC. | $14.26 | 2019 | |
| Portola Pharmaceuticals, LLC | $13.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isaac Tawfik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.